Oral tolerance: Elucidation of mechanisms and application to treatment of autoimmune diseases

被引:0
作者
Fowler, E [1 ]
Weiner, HL [1 ]
机构
[1] BRIGHAM & WOMENS HOSP, CTR NEUROL DIS, BOSTON, MA 02115 USA
关键词
oral tolerance; hyporesponsiveness; oral administration of protein; antigen; regulatory T cells; cytokines; inflammation; autoimmune diseases;
D O I
10.1002/(SICI)1097-0282(1997)43:4<323::AID-BIP5>3.0.CO;2-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oral tolerance is the phenomenon of systemic, antigen specific, immunological hyporesponsiveness that results from oral administration of a protein. The mechanism by which tolerance is generated depends on the amount of antigen administered; low doses favor induction of regulatory T cells while higher doses favor clonal deletion and anergy. The regulatory T cells induced by low doses of oral antigen are triggered by the same antigen to secrete cytokines that suppress, in an antigen nonspecific manner, inflammation in the microenvironment where the triggering antigen is located. This makes possible the targeted delivery of antiinflammatory cytokines to a specific tissue without the requirement for identifying the antigen causing the inflammation. This attribute makes active suppression an attractive mechanism Sor developing therapies for autoimmune diseases. Orally administered autoantigens have been shown to suppress a wide variety of experimental autoimmune diseases and have recently been applied to the treatment of human autoimmune diseases with promising early results. (C) 1997 John Wiley & Sons, Inc.
引用
收藏
页码:323 / 335
页数:13
相关论文
共 100 条
[51]  
MILLER A, 1993, J IMMUNOL, V151, P7307
[52]   SUPPRESSION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY ORAL-ADMINISTRATION OF MYELIN BASIC-PROTEIN .5. HIERARCHY OF SUPPRESSION BY MYELIN BASIC-PROTEIN FROM DIFFERENT SPECIES [J].
MILLER, A ;
LIDER, O ;
ALSABBAGH, A ;
WEINER, HL .
JOURNAL OF NEUROIMMUNOLOGY, 1992, 39 (03) :243-250
[53]  
MILLER JFAP, 1992, ANNU REV IMMUNOL, V10, P51, DOI 10.1146/annurev.immunol.10.1.51
[54]   The expanding universe of T-cell subsets: Th1, Th2 and more [J].
Mosmann, TR ;
Sad, S .
IMMUNOLOGY TODAY, 1996, 17 (03) :138-146
[55]   THE REGULATION OF IMMUNE-RESPONSES TO DIETARY-PROTEIN ANTIGENS [J].
MOWAT, AM .
IMMUNOLOGY TODAY, 1987, 8 (03) :93-98
[56]  
MOWAT AM, 1994, HDB MUCOSAL IMMUNOLO, P185
[57]   SUPPRESSION OF TYPE-II COLLAGEN-INDUCED ARTHRITIS BY INTRAGASTRIC ADMINISTRATION OF SOLUBLE TYPE-II COLLAGEN [J].
NAGLERANDERSON, C ;
BOBER, LA ;
ROBINSON, ME ;
SISKIND, GW ;
THORBECKE, GJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (19) :7443-7446
[58]   Effect of oral beta interferon on subsequent immune responsiveness [J].
Nelson, PA ;
Akselband, Y ;
Dearborn, SM ;
Alsabbagh, A ;
Tian, ZJ ;
Gonnella, PA ;
Zamvil, SS ;
Chen, YH ;
Weiner, HL .
ORAL TOLERANCE: MECHANISMS AND APPLICATIONS, 1996, 778 :145-155
[59]   Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance [J].
Neurath, MF ;
Fuss, I ;
Kelsall, BL ;
Presky, DH ;
Waegell, W ;
Strober, W .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (06) :2605-2616
[60]   Intraocular inflammatory disease (uveitis) and the use of oral tolerance - A status report [J].
Nussenblatt, RB ;
Whitcup, SM ;
deSmet, MD ;
Caspi, RR ;
Kozhich, AT ;
Weiner, HL ;
Vistica, B ;
Gery, I .
ORAL TOLERANCE: MECHANISMS AND APPLICATIONS, 1996, 778 :325-337